Chargement en cours...
Tremelimumab: research and clinical development
The immune checkpoint therapy is a relatively recent strategy that aims to tweak the immune system to effectively attack cancer cells. The understanding of the immune responses and their regulation at the intracellular level and the development of fully humanized monoclonal antibodies are the pillar...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809326/ https://ncbi.nlm.nih.gov/pubmed/27042127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S65802 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|